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The HIV Care Cascade Among Female Sex Workers in
Zimbabwe: Results of a Population-Based Survey From the
Sisters Antiretroviral Therapy Programme for Prevention of
HIV, an Integrated Response (SAPPH-IRe) Trial
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Introduction: Female sex workers (FSW) in sub-Saharan Africa
have a higher prevalence of HIV than other women of reproductive
age. Social, legal, and structural barriers inﬂuence their access to
care. Little is known about the HIV diagnosis and care cascade in
most countries in Southern Africa. We aimed to describe the HIV
diagnosis and care cascade among FSW in Zimbabwe.
Methods: We conducted cross-sectional respondent driven sampling
(RDS) surveys of FSW in 14 sites across Zimbabwe as the baseline for
a cluster-randomised controlled trial investigating a combination HIV
prevention and care package. We administered a questionnaire, tested
women for HIV and measured viral load. We report the mean, minimum,
and maximum respondent-driven sampling-2 weighted site values.
Results: The survey included 2722 women, approximately 200 per
site. The mean HIV prevalence was 57.5% (42.8–79.2 site minimum
and maximum). Of HIV-positive women, 64.0% (51.6–73.7) were
aware of their status, 67.7% (53.4–84.1) of these reported taking
antiretroviral therapy, and 77.8% (64.4–90.8) of these had a sup-
pressed HIV viral load (,1000 copies/mL). Among all HIV-positive
women, 49.5% had a viral load , 1000 copies/mL.
Conclusions: Although most HIV-positive women aware of their
status are accessing antiretroviral therapy, 36.0% of HIV-positive
women are unaware of their status and 29.3% of all FSW have an
unsuppressed HIV viral load. Investigation and investment into
models of testing, treatment, and care are necessary to reach
UNAIDS targets for HIV elimination.
Key Words: antiretroviral therapy, HIV seroprevalence, HIV viral
load, sex workers, Africa, Pragmatic Clinical Trial
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INTRODUCTION
In sub-Saharan Africa, female sex workers (FSW) have
high HIV incidence and prevalence and therefore are in
particular need of good access to effective HIV testing,
prevention, and treatment services.1 In sub-Saharan Africa,
FSW are estimated to have 13.5 times higher odds of HIV
infection than in the general population of adult women.1
However, FSW are a marginalized group, sex work is illegal
in many countries including Zimbabwe,2 and FSW are often
stigmatized by communities and health workers.3,4 Typically,
FSW are also highly mobile.5 Designing service-delivery
approaches that meet the needs of this population is therefore
complex but urgently needed.
There is currently little information about the continuum
of care from diagnosis to virological suppression (the HIV care
cascade) among FSW with which to guide programing.
Previous studies of FSW in sub-Saharan Africa indicate that
antiretroviral therapy (ART) can be provided to FSW6 at costs
comparable with that of provision in the general population.7 A
recent systematic review and meta-analysis of antiretroviral
uptake, adherence, and outcomes among FSW found that
current ART use among HIV-positive FSW was 39% (95%
conﬁdence interval: 29%–48%), but noted a concerning lack of
published data available.8 Another review of the provision of
sexual and reproductive health services for FSW in Africa
found little emphasis among programs on access to antiretro-
viral treatment and support for adherence.9 Although there is
some evidence to guide the design of HIV prevention programs
for FSW in Africa, little is known about the best means to
improve testing, access, and adherence to ART and effective
use of preexposure prophylaxis.10,11
In 2009, in response to a situational analysis conducted
among FSW by Zimbabwe’s National AIDS Council and
partners,12 the “Sisters with a Voice” program was established
in 5 sites, and has since expanded to 36 sites covering all the
provinces of Zimbabwe. Services provided are based on
guidance from the World Health Organization13 and include
HIV testing and counseling, sexual and reproductive health
services, condom provision, and health education supported by
trained peer educators and a program of community mobiliza-
tion. Results of a respondent-driven sampling (RDS) survey
conducted in 3 towns in 2011,14 along with qualitative work,15
suggested that FSW in Zimbabwe were poorly engaged with
HIV prevention and care services.
In response to this ﬁnding, we launched the Sisters
Antiretroviral Programme for Prevention of HIV—an Inte-
grated Response (SAPPH-IRe) trial, a cluster-randomized
controlled trial conducted in 14 sites around Zimbabwe
(7 matched-pairs). The aim is to determine the effectiveness
and cost effectiveness of an enhanced community–based
intervention to increase uptake, retention, and adherence to
antiretroviral-based prevention and therapy among FSW.
Outcomes were assessed at a population level in all 14
communities among FSW recruited to RDS surveys at
baseline (December 2013), and will also be assessed at end-
line (April 2016–May 2016).
Aiming to contribute to our scant knowledge of the
HIV diagnosis and care cascade among FSW in sub-Saharan
Africa, this article describes the HIV diagnosis and care
cascade at 14 sites around Zimbabwe at the baseline of the
SAPPH-IRe trial. Data are presented on sociodemographic
characteristics, HIV prevalence, ART coverage, viral sup-
pression, and the proportion of all FSW with unsuppressed
HIV viral load: the primary endpoint for the SAPPH-IRe trial.
METHODS
Study Population and Setting
Fourteen of the 36 sites where the “Sisters” services are
provided are included in the SAPPH-IRe trial. These sites
were purposively selected to reﬂect different sex work
location types (eg, town, growth point, colliery/army base),
were locations of adequate size (85–300 FSW attending
clinics annually), and were geographically disparate
to minimize contamination during the trial. Women were
eligible if they were aged 18 or elder, had exchanged in sex
for money or gifts in the preceding 30 days, and had lived at
the site for at least the previous 6 months.
Data Collection
We conducted RDS16 surveys of FSW using identical
procedures in each of the 14 sites. We used RDS because it
was unfeasible to assemble a sampling frame of the intended
target population; it has been recommended for research
among hard-to-reach populations17; we successfully con-
ducted similar RDS surveys of FSW in 3 locations in
2011,14 and sex work in these settings is not conducted
primarily within brothels or set venues making time-location
sampling methods less appropriate. In each site, we ﬁrst
conducted 2–3 days of geographic and social mapping,
including informal discussions with trained peer educators,
health care staff, and community informants. This formative
work informed speciﬁc criteria for purposely selected “seed”
women to ensure that all subpopulations within the site’s sex
worker population were represented and helped determine
how many of these seeds should be selected.18
In line with RDS methodology, seed participants in
each site were interviewed and given 2 recruitment coupons
to pass on to their sex worker peers. Women were uniformly
advised to recruit other sex workers whose names they knew
and who knew theirs, who had not already enrolled in the
study, and who met the study eligibility criteria. Interviewers
used screening questions to conﬁrm as far as possible that
women given coupons met these criteria when they presented
for interview. Six seeds were recruited in the smaller sites,
whereas in 4 larger sites 8 seeds were recruited. When women
receiving the coupons attended for the interview (“recruits”),
they were also given 2 coupons to give out to women they
knew who worked as FSW in that location. Coupons were
coded such that recruiter/recruitee relationships could be
tracked and unique IDs recorded. In all 14 sites, a maximum
of 5 iterations, or “waves,” of this process were performed
(6 waves, including the initial seeds). We aimed to recruit 200
FSW per site to give adequate power to detect the interven-
tion effect at follow-up.19 In line with other RDS surveys,
Cowan et al J Acquir Immune Defic Syndr  Volume 74, Number 4, April 1, 2017
376 | www.jaids.com Copyright © 2016 Wolters Kluwer Health, Inc. All rights reserved.
Copyright  2017 Wolters Kluwer Health, Inc. Unauthorized reproduction of this article is prohibited.
women were reimbursed for participating in the survey ($5)
and for recruiting eligible participants ($2 for each recruited).
All participants gave informed consent to participate after
receiving information about the study from trained inter-
viewers and being given the opportunity to ask questions.
Five teams of trained researchers undertook data
collection between November 13, 2013 and December 20,
2013. Interviewer-administered questionnaire data were col-
lected onto tablet computers and directly loaded into a master
database using a wireless internet connection in the ﬁeld.
Questionnaires included information on demographics, sex
work, sexual behavior and condom use, HIV testing history,
ART use, stigma, experience of violence, relationships with
other sex workers, and use of sexual, and reproductive health
services. We also collected data to determine personal
network size, or “degree,” for RDS estimation. In our survey,
the degree was the number of FSW a participant reported
knowing personally, whose names they knew and who knew
theirs, who were at least 18 years old, lived at the site, and
whom the participant would consider recruiting to the study.
All women had a ﬁnger prick blood sample collected in
the form of a dried blood spot (DBS) for detection of HIV
antibody [AniLabsytems EIA kit (AniLabsystems Ltd,
OyToilette 3, FIN-01720, Finland)]. Blood samples were
air-dried on ﬁlter papers and stored at room temperature, then
transported biweekly to the Flow cytometry Laboratory in
Harare. If HIV antibodies were detected then the DBS sample
was tested for HIV viral load using NucliSENS EasyQ HIV-1
v2.0, both to conﬁrm HIV-positive status and to quantify the
viral load. For samples with a positive HIV antibody test, but
an undetectable viral load, a second conﬁrmatory enzyme-
linked immunosorbent assay was performed [Enzygnost Anti-
HIV 1/2 Plus ELISA (Germany)]. At 2 trial sites, plasma
samples were collected in addition to DBS and tested in
parallel using NucliSENS EasyQ HIV-1 v2.0, to permit
validation of the use of DBS for viral load quantiﬁcation.20
The Medical Research Council Zimbabwe, University
College London, and the London School of Hygiene and
Tropical Medicine gave ethical approval for the SAPPH-IRe
trial, including the baseline data collection and analysis. The
trial was also registered with the Research Council of
Zimbabwe, the Pan African Clinical Trials Registry
(PACTR201312000722390), and was approved by the Med-
icines Control Authority of Zimbabwe.
Data Analysis
We follow the recommendations of the STROBE-RDS
guidelines in reporting our study.21 First, we described the
sample recruited. A limitation of RDS is that it is difﬁcult to
describe nonparticipation rates because no sample frame is
present, and we did not conduct “exit interviews” of women
who had distributed coupons to ascertain how many of their
peers refused to take part. We calculated cluster-summaries
for key sociodemographic characteristics of the sample. We
calculated and report the mean of the 14 cluster-level RDS-2
weighted summaries and the range of estimates across
clusters (minimum and maximum). Both as a total and
summarized across clusters, we described the proportion of
participants with suppressed HIV viral load, (,1000 copies/mL,
as per World Health Organization guidelines22,23), and
steps of the HIV care cascade underlying this: the proportion
who were found to be HIV positive; the proportion who
reported through questionnaire previously testing positive
(ie, knew their status); the proportion who reported being on
ART; and the proportion who had a viral load of ,1000
copies/mL. We described these estimates both as proportions
of the previous step on the cascade and as proportions of the
total of women testing HIV positive.
We used “RDS-2” to conduct all analyses, which uses
the “Volz-Heckathorn” estimator24 and has been found to be
less biased than previous estimators.25 RDS-2 is based on
estimating the inclusion probabilities of each survey partic-
ipant, assuming the recruitment process can be modeled as
a “random walk” over the social network of FSW. Within this
model, the probability that each participant will be included is
approximated as the inverse of the reported degree. Estimates
were calculated in Stata 12 using the “rds” analysis pack-
age,26 which removes seeds from the proportion estimates.
RDS-2 estimation assumes that recruitment chains
progress such that ﬁnal estimates are no longer dependent
on the characteristics of the seeds, that recruitment does not
become conﬁned within subgroups of the FSW population
(“bottlenecks”), and assumes with-replacement sampling
even when women cannot participate more than once in
practice.25 We assessed these assumptions and their potential
for bias on estimates of HIV prevalence and suppressed viral
load for each site, using plots of the convergence of HIV and
viral suppression estimates over sample waves (“conver-
gence plots”) and plots of estimate convergence by seed
(“bottleneck plots”). We also examined the difference
between RDS-2 estimates and estimates produced using the
RDS “successive sampling” estimator27 for a range of
possible population sizes to assess the bias resulting from
assuming with-replacement sampling. These analyses were
guided by published advice about RDS diagnostics28 and
used the “rds” package for the R statistical language.29
Details of the diagnostic methods and results are given in
Appendix 1 (http://links.lww.com/QAI/A952).
RESULTS
RDS Recruitment and Estimation
In total, 2722 participants were recruited over 6 waves
in 14 sites. Of these participants, 90 were seeds, of whom 62
(68.9%) were HIV positive and 29 (32.2%) had HIV viral
load $ 1000 copies/mL. The number of nonseed “recruits”
varied from 147 to 212 per site. There were an additional 15
participants from 8 sites who were missing recruiter infor-
mation and who were treated as seeds and therefore dropped
from the estimation.
Estimates for the proportion of FSW with suppressed
viral load and for HIV prevalence seemed to converge well by
the ﬁnal sample wave for all sites except one for HIV
prevalence and 2 for viral load, and there was little evidence
of recruitment becoming conﬁned within subgroups from any
site (see Appendix 1).
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Characteristics of FSW
Participants were aged between 18 and 65, with a mean
age of 31 years (minimum site mean of 29 and maximum of
34). Approximately, one-third of women had no or only
primary education, another third had completed forms 1–3, and
the ﬁnal third had completed at least form 4 (Table 1). Very
few of the women were married (0.8% overall unweighted, the
proportion was too small to calculate RDS weights) and 61.9%
(range 46.4%–70.6% across sites) were separated or divorced.
Most women (53.5%) reported initiating sex work by 24 years
old, with 17.4% (8.5–25.9) reporting having started sex work
before they were 18 years old. In total, 8.2% reported having
no clients in the past week, 49.9% of women reported having
between 1 and 5 clients per week; and 13.2% reported
having 16 or more. Just under half of the women in each
cluster (45.0%) were food insecure (food insecurity was
indicated by any of the following: being unable to eat 2 meals
a day; sometimes going to bed hungry; going an entire day
without eating in the last week). More than a quarter of women
(26.7%) had worked at another geographic location in the
previous 12 months, whereas 52.2% had lived in their current
location for 6 or more years. Just under two thirds (61.4%) of
women reported good or very good relations with other FSW.
Violence from intimate partners was the most common
form of interpersonal violence ever experienced (40.3%),
followed by violence from clients (27.7%). Violence from
police in the previous year was 9.7% overall, although in one
location it was 19.5%.
Most participants reported having previously tested for
HIV (91.1%), and of those who were HIV negative 70.5% (52.7–
88.8) reported having tested for HIV in the previous 6 months.
HIV and the Diagnosis and Care Cascade
The HIV care cascade for HIV-positive FSW is described
in Figure 1. HIV prevalence among FSW was estimated to be
57.5%, ranging from 42.8% to 79.2% across sites.
Among those who tested HIV positive, an average of
64.0% (51.6–73.7) in each site were aware of their status, ie,
they reported a previous positive HIV test. Of those aware of
their positive status, 67.7% (53.4–84.1) reported taking ART,
which was 43.3% (32.3–54.0) of all those who tested HIV
positive in the study. Across sites, an average of 77.8% (64.4–
90.8) of women who were on ART had a viral load ,1000
copies/mL. Women on ART with viral loads,1000 copies/mL
were 33.7% (range 36.5–62.2) of all those testing HIV
positive. An additional 15.8% (range 12.6–16.6) of those
testing positive had a viral load ,1000 copies/mL, despite
not reporting being on ART. Of all HIV-positive FSW, 43.3%
(32.3–54.0) were on ART and 49.5% (36.5–62.2) had viral
loads of ,1000 copies/mL.
When considering all FSW as the denominator, there
were an estimated 29.3% (18.9–42.3) of women who had an
unsuppressed HIV viral load of $1000 copies/mL.
DISCUSSION
We analyzed data from 2722 FSW recruited in 14 sites
in Zimbabwe. HIV prevalence was very high (mean 57.5%
across sites, ranging 42.8%–79.2%). Although recent HIV
testing and access to ART were relatively common, still some
36.0% of HIV-positive FSW did not report that they were
positive in the research interview (26.3–48.4). Most women
who tested HIV positive and reported being aware of their
status reported accessing ART (67.7%) and of those, 77.8%
had a viral load ,1000 copies/mL. However, overall only
49.5% of all HIV-positive women had a viral load ,1000
copies/mL, in part because many were unaware of their status.
Signiﬁcant and rapid progress is needed to reduce HIV
infection rates, increase HIV status awareness, and improve
overall levels of viral suppression.
We undertook an ambitious ﬁeld study to collect
baseline data and test the feasibility of our proposed approach
to the trial end-line data collection. We have shown that it was
feasible to rapidly recruit approximately 200 FSW per site in
14 sites across Zimbabwe using RDS methodology. Our
ﬁndings make an important contribution to the sparse
literature on the HIV diagnosis and care cascade among
FSW in sub-Saharan Africa.8 We have been able to measure
women having unsuppressed viral load as a proportion of all
HIV-positive sex workers, not only among those accessing
ART, which is important given that approximately one-third
of HIV-positive FSW were unaware of their status. Sampling
approaches such as ours provide a key means for assessing
how close we are to the 90:90:90 targets30 in a given
population or setting.
All sampling methods for hard-to-reach populations
have limitations, and RDS is no exception. The estimation
makes many assumptions about the recruitment process and
the social networks of sex workers. Previous mapping of sex
workers in Zimbabwe suggests they are well networked.14,31
Critical is that appropriate statistical techniques are used
although there remains debate about methods of analysis. We
have undertaken a series of in-depth diagnostic tests to
determine the validity of RDS among FSW in these surveys,
and ﬁnd little evidence that there were major issues with
recruitment. We present diagnostics in Appendix 1. However,
as in all applications of RDS in hidden populations, it was not
possible for us to empirically verify the extent to which the
sample we recruited reﬂects the characteristics of FSWs
working in the 14 sites. A major strength of our study was
that we adopted identical ﬁeld procedures in each of the sites,
strengthening our capacity to compare ﬁndings across them.
Our estimate of viral load for HIV-positive FSW was
based on analysis of DBS samples. Although plasma analysis
is normally considered the gold-standard approach, DBS
seemed to be an acceptable method for viral load monitoring
using the NucliSENS assay, and we estimated high
DBS sensitivity compared with plasma “gold-standard”
(sensitivity = 87.4% and speciﬁcity = 96.8%).20
Coverage of ART among HIV-positive FSW was
similar at 43.4% (range 32.3–54.0) to the 40% we had
hypothesized before the trial.19 This was slightly higher but in
the range of the pooled estimate of 39.3% (27.2%–52.9%)
among sex workers from low and middle income in studies
found in a recent meta-analysis and systematic review.8 Some
67.7% of those FSW who were aware of their status and
reported they were positive also reported taking ART (range
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TABLE 1. Baseline Range and Means of Cluster-Level Summaries of Sociodemographic Characteristics of 2722 FSW From 14
Clusters
Characteristics of FSW Frequency, N Unweighted, %
RDS Weighted, Mean %
Across Sites, (Min–Max)
Age at interview, yrs
18–24 656 24.1 26.5 (9.9–38.4)
25–29 668 24.5 23.6 (17.8–33.1)
30–39 956 35.1 34.4 (22.7–45.1)
.40 442 16.2 15.5 (6.5–22.3)
Total 2722
Highest level of education that you have completed
None/primary 857 31.7 36.2 (17.5–54.9)
Form 1–3 966 35.7 35.3 (18.1–46.4)
Form 4+ 882 32.6 28.5 (18.4–40.8)
Total 2705
Marital status
Married 22 0.8 *
Divorced/separated 1710 62.8 61.9 (46.4–70.6)
Widowed 493 18.1 19.4 (9.5–39.2)
Never married 497 18.3 18.7 (6.8–39.3)
Total 2722
Age when ﬁrst exchanged sex for gifts or money
(ie, when ﬁrst started sex work), yrs
,18 492 18.1 17.4 (8.5–25.9)
18–19 173 6.4 6.2 (1.7–19.4)
20–24 839 30.8 29.9 (19.0–40.2)
25/29 650 23.9 25.6 (15.1–32.4)
.30 568 20.9 20.8 (8.9–26.5)
Total 2722
No. clients had sex with in the previous week
None 200 7.4 8.2 (3.1–13.6)
1–5 1352 49.7 49.9 (33.4–70.3)
6–10 578 21.2 21.8 (9.8–36.7)
11–15 218 8.0 6.9 (3.2–9.7)
.16 374 13.7 13.2 (3.5–31.3)
Total 2722
Insecure food quantity†
No 1513 55.6 —
Yes 1209 44.4 45.0 (27.0–74.5)
Total 2722
Worked as a sex worker at anywhere other than current
location in the last 12 mo
No 1987 73.0 —
Yes 734 27.0 26.7 (17.6–38.4)
Total 2721
How long lived at the site, yrs
0–1 274 10.1 13.4 (0.1–30.4)
2–5 855 31.5 34.4 (15.7–52.7)
.6 1582 58.4 52.2 (33.7–80.1)
Total 2711
Answered “very good” or “good” in response to “In
general how would you describe your relationship
with other sex workers in [SITE]?”
No 1050 38.6 —
Yes 1672 61.4 61.4 (50.0–77.0)
Total 2722
(continued on next page)
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53.4%–84.1%). This was similar to our ﬁndings in 3 sites in
2011, when we found 51%–74% HIV-positive FSWs who
were aware of their HIV status were also engaged with care.14
However, coverage is well below the target set by UNAIDS
(90% of people with HIV are aware of their infection, 90% of
people diagnosed with HIV are on ART, and 90% of those on
ART adhere and have undetectable levels of HIV in their
blood).30 Coverage among the general population of adult
women in Zimbabwe is not known.
Overall, 77.8% of those reporting taking ART had
a viral load ,1000 copies/mL, as did 15.8% of HIV-positive
women who did not report being on ART. That such a large
proportion of women not on ART had a suppressed viral load
was not anticipated; one explanation is that women under-
TABLE 1. (Continued ) Baseline Range and Means of Cluster-Level Summaries of Sociodemographic Characteristics of 2722 FSW
From 14 Clusters
Characteristics of FSW Frequency, N Unweighted, %
RDS Weighted, Mean %
Across Sites, (Min–Max)
Ever had a sexual partner (including a current or former
husband, boyfriend but NOT a client) that has hit,
slapped, kicked, pushed, shoved, or otherwise
physically hurt
No 1542 56.8 —
Yes 1172 43.2 40.3 (14.9–65.5)
Total 2714
Ever had a client that has hit, slapped, kicked, pushed,
shoved, or otherwise physically hurt
No 1897 69.7 —
Yes 825 30.3 27.7 (11.0–53.4)
Total 2722
In the past year has any member of the police been
sexually violent against you?
No 2569 94.4 —
Yes 152 5.6 4.6 (0–9.0)
Total 2721
In the past year has any member of the police been
physically violent against you?
No 2430 89.3 —
Yes 290 10.7 9.7 (1.8–19.5)
Total 2720
Consistent condom use with clients*
No 589 21.6 —
Yes 2133 78.4 76.7 (61.6–88.5)
Total 2722
Ever tested for HIV
No 213 7.8 —
Yes 2509 92.2 91.1 (82.5–96.9)
Total 2722
Tested for HIV within the last 6 months and not HIV
positive
No 331 29.5 —
Yes 792 70.5 70.5 (52.7–88.8)
Total 1123
HIV status
Negative 1109 41.0 —
Positive 1599 59.0 57.5 (42.8–79.2)
Total 2708
HIV viral load ,1000 copies/mL among all FSW
No 825 30.5 —
Yes 1883 69.5 70.7 (57.7–81.6)
Total 2708
*Reports using condom at last sex and answering “no” to “Think again about all your clients in the last month, have there been any times when you did not use condoms?”
†Answering “no” to “We can eat at least 2 meals a day,” or “yes” to “Sometimes we go to bed hungry,” or “yes” to “In the last week, have you had to go an entire day without
eating because there was no food in your household?”
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reported their knowledge of HIV status and ART usage.
However, there have been other surveys with similar ﬁndings:
the 2012 Kenya AIDS Indicator Survey found that 30% of
individuals who reported not being on ART were virally
suppressed32 and among men who have sex with men in the
United States reporting to be unaware of their status and
therefore not on ART in 2004–2011, 2/11 to 3/7 were found
to be virally suppressed.33 We plan to investigate this further.
These data point to an urgent need to improve HIV
prevention and care for FSW in Africa using comprehensive
community–based sex worker–led interventions.10 There is
good evidence of their cost effectiveness34,35 but in few
countries has comprehensive care as recommended by
WHO11 been taken to scale. Interventions that work across
the cascade are likely to be more scalable and cost effective
than those that work on only one aspect of the cascade.36
CONCLUSIONS
In conclusion, our ﬁndings have contributed to knowl-
edge of the HIV care cascade among sex workers in Southern
Africa. They conﬁrm the urgent need for HIV prevention and
care services in this population that address each step of the
care cascade. We hope that the SAPPH-IRe trial will
contribute to our understanding of how best to serve the
needs of FSW in the region.
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